US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Denali Capital Acquisition Corp. - Class A Ordinary Shares
(NQ:
DECA
)
11.43
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Denali Capital Acquisition Corp. - Class A Ordinary Shares
Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside
↗
August 21, 2025
The proceeds of the agreement will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural...
Via
Stocktwits
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
June 11, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
May 09, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
April 14, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.
April 10, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
March 11, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
February 11, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
January 08, 2025
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
December 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
November 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate
↗
October 16, 2024
Alliance Global Partners has initiated coverage on Scilex Holding Company. The company explores strategic options for its subsidiary, Scilex Pharma, including potential spinoffs and dividend...
Via
Benzinga
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
October 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
September 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination
September 03, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
August 09, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
July 10, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
↗
July 03, 2024
Semnur Pharmaceuticals, a subsidiary of Scilex, plans a business combination with Denali Capital Acquisition Corp. Semnur's lead product, SP-102 (SEMDEXA), a novel non-opioid pain therapy for sciatica,...
Via
Benzinga
Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
June 27, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
June 27, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 24, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
June 20, 2024
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning!
Via
InvestorPlace
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
June 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
May 10, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
April 11, 2024
From
Denali Capital Acquisition Corp.
Via
GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 09, 2024
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
Via
Benzinga
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
↗
January 27, 2023
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I...
Via
Benzinga
